Please assess the completion status of the following clinical trial:

Trial Title: Probiotics for Prevention Neonatal Infection

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* All newborn infants in the community \>24 hours and \<72 hours of age~* 2000 g at birth~* Breastfeeding begun by 24 hr of life~* Able to tolerate oral feeds~* Informed consent by parent or guardian~Exclusion Criteria:~* Evidence or suspicion of clinical sepsis before the baby is randomized~* Not on breast feeding by 24 hr~* Inability to establish oral feeds (in case of maternal death or ailment)~* Presence of major congenital anomalies

- Gender: ALL
- Minimum Age: 1 Day
- Maximum Age: 3 Days
- Healthy Volunteers: t

Study Arms:
- Probiotic group (Type: EXPERIMENTAL): Once daily oral administration of a probiotic preparation (1 billion cells of Lactobacillus plantarum and 150 mg of fructooligosaccharides) for one week to newborn infants
- Placebo (Type: PLACEBO_COMPARATOR): Once daily oral administration of maltodextrin for one week to newborn infants

Based on this trial design, predict the completion outcome and termination type (if applicable).